Back to Search Start Over

Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

Authors :
Jacques Izopet
Pascal Lebray
Marie Essig
Robert N. Santella
Anne Marie Roque-Afonso
Valérie Garrigue
Nada Kanaan
Amelie Cannesson
Nassim Kamar
Elisabeth Cassuto-Viguier
Lionel Rostaing
Elizabeth B. Haagsma
Filomena Conti
Cyril Garrouste
Sven Pischke
Christiane Mousson
Sylvie Radenne
Harry R. Dalton
Jérôme Dumortier
Cecile Chauvet
Eric Thervet
Service de Néphrologie - Hypertension Artérielle Dialyse - Transplantation
CHU Toulouse [Toulouse]-Hôpital de Rangueil
CHU Toulouse [Toulouse]
Centre de Physiopathologie Toulouse Purpan (CPTP)
Université Toulouse III - Paul Sabatier (UT3)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Université Fédérale Toulouse Midi-Pyrénées
Service de virologie
CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse]
Department of Gastroenterology and Hepatology
University Medical Center Groningen [Groningen] (UMCG)
Service de Pédiatrie spécialisée
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School [Hannover] (MHH)
Département de néphrologie et transplantation
Hospices Civils de Lyon (HCL)-Hôpital Edouard Herriot [CHU - HCL]
Hospices Civils de Lyon (HCL)
service d'Hépato-gastro-entérologie
Hospices Civiles de Lyon-Hôpital Edouard Heriault
service de néphrologie et transplantation
Centre Hospitalier Universitaire de Nice (CHU Nice)
Service de néphrologie adultes [CHU Necker]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Service d'hépatologie [Saint-Antoine]
CHU Saint-Antoine [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Université Pierre et Marie Curie - Paris 6 (UPMC)
Service d'Hépato-Gastro-Entérologie [CHU Pitié-Salpêtrière]
CHU Pitié-Salpêtrière [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
European Centre for Environment and Human Health
Royal Cornwall Hospital-Universities of Exeter and Plymouth
North Central Kidney Institute
Avera Mckennan Hospital-University Health Center
Service de néphrologie
Saint-Luc Hospital
Service de Néphrologie, Dialyse, Transplantations [CHU Limoges]
CHU Limoges
Service de néphrologie (CHU de Dijon)
Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)
Service d'hépatologie
Hospices Civils de Lyon (HCL)-Hôpital de la Croix-Rousse [CHU - HCL]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse
Laboratoire de Virologie [Purpan]
CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan
Hôpital Purpan [Toulouse]
CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse]
Centre de Physiopathologie Toulouse Purpan (ex IFR 30 et IFR 150)
Université Toulouse III - Paul Sabatier ( UPS )
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR30-IFR150-Institut National de la Santé et de la Recherche Médicale ( INSERM )
University Medical Center Groningen
Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie
Hannover Medical School [Hannover] ( MHH )
Hospices Civils de Lyon ( HCL ) -Hôpital Edouard Herriot [CHU - HCL]
Hospices Civils de Lyon ( HCL )
CHU Nice
CHU Necker - Enfants Malades [AP-HP]-Assistance publique - Hôpitaux de Paris (AP-HP)
Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Saint-Antoine [APHP]
Service d'Hépato-Gastroentérologie [CHU Pitié-Salpêtrière]
Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP]
Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon )
Hospices Civils de Lyon ( HCL ) -Hôpital de la Croix-Rousse [CHU - HCL]
Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Paul Brousse
Marquet, Pierre
Laboratoire Virologie [CHU Toulouse]
Institut Fédératif de Biologie (IFB)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse]
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Service d'hépatologie [CHU Saint-Antoine]
Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Royal Cornwall Hospital-Plymouth University
Source :
Gastroenterology, Gastroenterology, WB Saunders, 2011, 140 (5), pp.1481-9. ⟨10.1053/j.gastro.2011.02.050⟩, Gastroenterology, 140(5), 1481-1489. W B SAUNDERS CO-ELSEVIER INC, Gastroenterology, WB Saunders, 2011, 140 (5), pp.1481-9. 〈10.1053/j.gastro.2011.02.050〉, Gastroenterology, 2011, 140 (5), pp.1481-9. ⟨10.1053/j.gastro.2011.02.050⟩
Publication Year :
2011
Publisher :
HAL CCSD, 2011.

Abstract

International audience; BACKGROUND & AIMS: Hepatitis E virus (HEV) infection can cause chronic hepatitis in recipients of solid organ transplants. However, the factors that contribute to chronic infection and the outcomes of these patients are incompletely understood. We performed a retrospective analysis of data from 17 centers from Europe and the United States that described the progression, outcomes, and factors associated with development of chronic HEV infection in recipients of transplanted solid organs. METHODS: We studied data from 85 recipients of solid organ transplants who were infected with HEV. Chronic HEV infection was defined by the persistent increases in levels of liver enzymes and polymerase chain reaction evidence of HEV in the serum and/or stool for at least 6 months. RESULTS: Fifty-six patients (65.9%) developed chronic hepatitis. Univariate analysis associated liver transplant, shorter times since transplant, lower levels of liver enzymes and serum creatinine, lower platelet counts, and tacrolimus-based immunosuppressive therapy (rather than cyclosporin A) with chronic hepatitis. On multivariate analysis, the independent predictive factors associated with chronic HEV infection were the use of tacrolimus rather than cyclosporin A (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.49-1.97; P = .004) and a low platelet count at the time of diagnosis with HEV infection (OR, 1.02; 95% CI, 1.001-1.1; P = .04). Of patients with chronic hepatitis, 18 (32.1%) achieved viral clearance after the dose of immunosuppressive therapy was reduced. No HEV reactivation was observed after HEV clearance. CONCLUSIONS: HEV infection causes chronic hepatitis in more than 60% of recipients of solid organ transplants. Tacrolimus therapy is the main predictive factor for chronic hepatitis. Dose reductions of immunosuppressive therapy resulted in viral clearance in more than 30% of patients.

Subjects

Subjects :
Male
MESH : Retrospective Studies
CYCLOSPORINE-A
medicine.medical_treatment
MESH : Aged
Liver transplantation
medicine.disease_cause
Polymerase Chain Reaction
MESH : Hepatitis E virus
THERAPY
Organ transplantation
MESH : Organ Transplantation
Liver disease
0302 clinical medicine
Hepatitis E virus
Cyclosporin a
MESH : Female
MESH: Incidence
MESH : Polymerase Chain Reaction
Hepatitis, Chronic
MESH: Aged
0303 health sciences
MESH: Middle Aged
Incidence
Liver Disease
Gastroenterology
MESH: Follow-Up Studies
Middle Aged
MESH : Adult
[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences
LIVER-TRANSPLANTATION
MESH : Incidence
3. Good health
Hepatitis E
Virus
PREVALENCE
[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences
Europe
MESH: Young Adult
BLOOD-DONORS
MESH: RNA, Viral
RNA, Viral
030211 gastroenterology & hepatology
Female
Adult
MESH: Hepatitis E virus
medicine.medical_specialty
MESH : United States
MESH : Male
MESH: Hepatitis, Chronic
MESH : Europe
MESH : Young Adult
FRANCE
MESH: Organ Transplantation
03 medical and health sciences
Young Adult
medicine
MESH: United States
Humans
MESH : RNA, Viral
MESH : Hepatitis, Chronic
MESH : Middle Aged
KIDNEY-TRANSPLANT
030304 developmental biology
Aged
Retrospective Studies
Hepatitis
Transplantation
MESH: Humans
Hepatology
business.industry
MESH : Humans
MESH: Hepatitis E
MESH : Follow-Up Studies
MESH: Adult
MESH: Polymerase Chain Reaction
MESH: Retrospective Studies
Organ Transplantation
medicine.disease
Fibrosis
Tacrolimus
United States
MESH: Male
Chronic infection
RECIPIENTS
[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical sciences
MESH : Hepatitis E
Immunology
REPLICATION
PEGYLATED INTERFERON-ALPHA
MESH: Europe
business
MESH: Female
Follow-Up Studies

Details

Language :
English
ISSN :
00165085 and 15280012
Database :
OpenAIRE
Journal :
Gastroenterology, Gastroenterology, WB Saunders, 2011, 140 (5), pp.1481-9. ⟨10.1053/j.gastro.2011.02.050⟩, Gastroenterology, 140(5), 1481-1489. W B SAUNDERS CO-ELSEVIER INC, Gastroenterology, WB Saunders, 2011, 140 (5), pp.1481-9. 〈10.1053/j.gastro.2011.02.050〉, Gastroenterology, 2011, 140 (5), pp.1481-9. ⟨10.1053/j.gastro.2011.02.050⟩
Accession number :
edsair.doi.dedup.....f9c5a623ec45419d8c17e88de4e5e4e6